Preoperative Durvalumab (D) With Or Without Tremelimumab (T) For Resectable Head And Neck Squamous Cell Carcinoma (Hnscc) M. H. Hong,C. G. Kim,D. H. Kim,S. M. Lim,B-C. Ahn,S-H. Kim,Y. M. Park,H. Park,G. Park, I. Jung,B. C. Cho, Y. W. Koh,H. R. KimANNALS OF ONCOLOGY(2021)引用 5|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要